Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Safety and Tolerability Study of Vitargus® in Vitrectomy Surgery

NCT04481386 is registered in ClinicalTrials.gov with BioFirst Corporation as lead sponsor.

NCT NCT04481386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04481386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Safety and Tolerability Study of Vitargus® in Vitrectomy Surgery
Lead sponsor
BioFirst Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2017
Completion date
July 2, 2018
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitreo-retinal surgery